Related Experiment Video
Updated: Jan 13, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine
Abstract:
Extensive 3' alternative splicing of the mu opioid receptor gene OPRM1 creates multiple C-terminal splice variants. However, their behavioral relevance remains unknown. The present study generated 3 mutant mouse models with truncated C termini in 2 different mouse strains, C57BL/6J (B6) and 129/SvEv (129). One mouse truncated all C termini downstream of Oprm1 exon 3 (mE3M mice), while the other two selectively truncated C-terminal tails encoded by either exon 4 (mE4M mice) or exon 7 (mE7M mice). Studies of these mice revealed divergent roles for the C termini in morphine-induced behaviors, highlighting the importance of C-terminal variants in complex morphine actions. In mE7M-B6 mice, the exon 7-associated truncation diminished morphine tolerance and reward without altering physical dependence, whereas the exon 4-associated truncation in mE4M-B6 mice facilitated morphine tolerance and reduced morphine dependence without affecting morphine reward. mE7M-B6 mutant mice lost morphine-induced receptor desensitization in the brain stem and hypothalamus, consistent with exon 7 involvement in morphine tolerance. In cell-based studies, exon 7-associated variants shifted the bias of several mu opioids toward β-arrestin 2 over G protein activation compared with the exon 4-associated variant, suggesting an interaction of exon 7-associated C-terminal tails with β-arrestin 2 in morphine-induced desensitization and tolerance. Together, the differential effects of C-terminal truncation illustrate the pharmacological importance of OPRM1 3' alternative splicing.
Insights
Alternative splicing of the mu opioid receptor gene (OPRM1) creates variants impacting morphine effects. Truncating C-terminal tails reveals distinct roles in tolerance, reward, and desensitization.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Alternative splicing of the mu opioid receptor gene (OPRM1) generates numerous C-terminal variants.
- The behavioral significance of these OPRM1 splice variants is largely unexplored.
Purpose of the Study:
- To investigate the functional roles of OPRM1 C-terminal splice variants in morphine-induced behaviors.
- To generate and characterize mouse models with specific truncations of OPRM1 C-terminal tails.
Main Methods:
- Generated three mutant mouse models (mE3M, mE4M, mE7M) in C57BL/6J and 129/SvEv strains with truncated OPRM1 C termini.
- Assessed morphine-induced behaviors including tolerance, reward, and physical dependence.
- Conducted cell-based assays to examine receptor signaling bias and desensitization.
Main Results:
- Truncations differentially affected morphine tolerance, reward, and dependence.
- Exon 7 truncation diminished tolerance and reward but not dependence.
- Exon 4 truncation enhanced tolerance and reduced dependence.
- mE7M mice showed loss of morphine-induced desensitization in specific brain regions.
- Cell studies indicated exon 7 variants bias mu opioid signaling towards β-arrestin 2.
Conclusions:
- OPRM1 C-terminal splice variants play critical, distinct roles in mediating complex morphine actions.
- Alternative splicing of OPRM1 is pharmacologically significant for opioid drug effects.
- Exon 7-associated variants are implicated in morphine tolerance via β-arrestin 2 interactions.
More Related Videos
07:48Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Related Concept Videos
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
RNA Splicing